9 Strategic Shifts in the 2026 Pharmacovigilance Market: AI-Driven Signal Detection and Real-World Evidence Integration
As of February 2026, the global life sciences sector is witnessing a transformative realignment of drug safety protocols, with the Pharmacovigilance Market transitioning from a reactive compliance function to a proactive, data-driven strategic asset. The increasing complexity of biologic therapies and the acceleration of orphan drug approvals have necessitated the adoption of...
0 Comments 0 Shares 23 Views 0 Reviews